explore -WSS

explore

author：hotspot 2025-09-30 17:44:24 - browse：3511

A syringe is prepared at a clinic in Norristown, Pa., Dec. 7, 2021. The Environmental Protection Agency finalized a rule Thursday, March 14, 2024, imposing stricter limits on a chemical used to sterilize medical equipment after finding a higher-than-expected cancer risk at facilities that use ethylene oxide to clean billions of devices including catheters and syringes. ( — The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. Matt Rourke/Ap

On Thursday, the Environmental Protection Agency finalized limits on a carcinogenic gas called ethylene oxide that is used to sterilize most medical devices. Sterilizing facilities had polluted the air unchecked for decades, leading to disproportionately high cancer risks in surrounding communities.

The agency first proposed limits on the gas in April 2023, with the goal of reducing emissions by 80%. Now, the agency is predicting an emissions reduction of 90%. The rule will require commercial sterilization facilities to monitor and submit proof of their reduced emissions. It aligns with the Biden administration’s greater mission to end cancer and commitment to environmental justice, the EPA said.

Ethylene oxide is the most frequently used sterilizing chemical for devices that can’t be exposed to steam. It’s used to sanitize 20 billion devices in the U.S. per year, such as pacemakers, catheters, and ventilators. But long-term exposure to the gas can cause breast cancer, non-Hodgkin’s lymphoma, lymphocytic leukemia, and myeloma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： HCA sued by state AG for quality issues at Mission Health

entertainment

leisure time

WSS

CDC picks Alphabet's Verily for wasterwater surveillance contract

David Ricks of Eli Lilly: best biopharma CEO of 2023

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Stop Congress from blocking public access to science

David Ricks of Eli Lilly: best biopharma CEO of 2023

entertainment

explore

focus

In Memoriam: Notable people who died in 2023

Will an HIV vaccine ever be a reality?

At least 13 dead in Texas as scorching temps continue

The Karikó problem: Lessons for funding basic research

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare drug price negotiation hasn't dried up venture capital

Duchenne breakthrough therapy leaves behind pioneering families

The United States is paying nearly triple for new Covid vaccines

Activists slam private health insurers over coverage restrictions

Some top drug companies are starting to take action on climate

entertainment

Flu, Covid vaccination rates decline, new survey data show

With Roe v Wade overturned, abortion providers work to adapt

Setback for rare diseases as Taysha Gene Therapies pulls back

Setback for rare diseases as Taysha Gene Therapies pulls back

Medicare innovation center doesn’t save money, experts say

The biotech scorecard for Q4: 16 stock

entertainment

hotspot

leisure time

knowledge